Alibaba Group Holding Ltd BABA is scheduled to host its analyst day on June 14, in Hangzhou.
Robert "Bob" Peck of SunTrust Robinson Humphrey maintains a Buy rating on the company, with a price target of $90.
10 Topic Areas
“Investors we speak with are looking forward to a deeper understanding of the financials and growth profiles for the core business as well as investment areas,” Peck mentioned, while listing the 10 topics to focus on for Analyst Day.
1. Strength of the core, including revenue growth and GMV at Tmall and Taobao, buyer and sellers, unit growth, penetration and TAM, take rate growth in mobile and desktop, as well as key category strength and challenges.
2. Health of the Chinese economy, including mix shift to consumption, overall growth of the economy and the impact on Alibaba.
3. “Decoupling of Revenue and GMV Growth,” with a focus on growth of brand advertising, Alimama and TANX, advertising tools, logistics, commission rates, cross border issue and DAUs.
Related Link: Alibaba's Softbank Monetization Impact Minimized By Buyback, Trust Structure
4. Logistics associated with Cainiao, including the current situation and outlook, shareholder and control structure; costs and profitability; scale and efficiency; and requirement for incremental investments.
5. The competitive landscape; competitive categories; exclusive sellers and products; international and cross border competition; and promotional activity.
6. The cloud opportunity with Aliyun, including investment levels, margin structure, executive team, international growth potential and competition.
7. Ant Financial, including products offers, regulatory landscape, key operating metrics, size and growth.
8. Information on specific segments, including growth and expansion in wholesale and international, as well as the Youku integration, Lazada, Autonavi and UCWeb.
9. Strategic partnerships, including those with Softbank, Suning, O2O/Koubie, Alibaba Health, Alibaba Pictures, Paytm, Weibo, Snapdeal and more.
10. The SEC investigation and accounting issues, including the scope and timing.© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
